chevron_leftBack
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd.
002864
30.24CNY
-0.2%
4.47 USD
As of 15 June 2026, Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd. has a market cap of $473.74M USD, ranking #15474 globally and #4847 in China.
It ranks #1379 in the Healthcare sector, and #509 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$473.74MUSD
3.21B CNY
Enterprise Value
$315.4MUSD
2.13B CNY
Revenue (TTM)
$164.29MUSD
1.11B CNY
EBITDA (TTM)
$24.14MUSD
163.39M CNY
Net Income (TTM)
$12.81MUSD
86.79M CNY
EBITDA Margin
15%
Profit Margin
7.8%
PE Ratio
36.5
PS Ratio
2.9
PB Ratio
1.9
EV/EBITDA
13.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Dezhu Zhang
open_in_new
Employees
933
Founded
1997
Website
pljt.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.2% | -2% | -8.5% | -13% | -1.8% | 14% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
002864
陕西盘龙药业集团股份有限公司 Class A
ISIN: CNE1000032C9
Shares Out.:
Shares Outstanding:
104.408M1
Shares Float:
52.964M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
30.24 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd was founded in 1997 and is based in Xi'an, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
11K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
10K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
6K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
4K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
3K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
3K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
161K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
115K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
76K%
|
97.4
|
|
SIX: RO
|
$321.52B
68K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
61K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
58K%
218.9B CHF
|
20.5
|
chevron_leftBack